ARTICLE | Clinical News
Inovio preclinical data
September 2, 2013 7:00 AM UTC
In mice and non-human primates, Inovio's SynCon malaria DNA vaccine produced "robust and sustained" antibody responses to all 4 malaria antigens tested, according to the company. The vaccine also indu...